<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-00849643</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-21T00:43:21+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Influence on Busilvex pharmacokinetics of clonazepam compared to previous phenytoin historical data.</title>
            <author role="aut">
              <persName>
                <forename type="first">E.</forename>
                <surname>Carreras</surname>
              </persName>
              <idno type="halauthorid">725981-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">J. Y.</forename>
                <surname>Cahn</surname>
              </persName>
              <idno type="halauthorid">709469-0</idno>
              <affiliation ref="#struct-388270"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">C.</forename>
                <surname>Puozzo</surname>
              </persName>
              <idno type="halauthorid">505941-0</idno>
              <affiliation ref="#struct-132311"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">N.</forename>
                <surname>Kröger</surname>
              </persName>
              <idno type="idhal" notation="numeric">763386</idno>
              <idno type="halauthorid" notation="string">725982-763386</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-2961-4183</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">G.</forename>
                <surname>Sanz</surname>
              </persName>
              <idno type="halauthorid">725983-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">A.</forename>
                <surname>Buzyn</surname>
              </persName>
              <idno type="halauthorid">423568-0</idno>
              <affiliation ref="#struct-19365"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">A.</forename>
                <surname>Bacigalupo</surname>
              </persName>
              <idno type="halauthorid">725984-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">J. P.</forename>
                <surname>Vernant</surname>
              </persName>
              <idno type="halauthorid">440715-0</idno>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Marie-Claire</forename>
                <surname>Dagher</surname>
              </persName>
              <email type="md5">16a92a66fdebde7a6e37680303039cc5</email>
              <email type="domain">ibs.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2013-07-31 15:37:07</date>
              <date type="whenModified">2025-09-27 19:30:40</date>
              <date type="whenReleased">2013-07-31 15:37:07</date>
              <date type="whenProduced">2010-07</date>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="140374">
                <persName>
                  <forename>Marie-Claire</forename>
                  <surname>Dagher</surname>
                </persName>
                <email type="md5">16a92a66fdebde7a6e37680303039cc5</email>
                <email type="domain">ibs.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-00849643</idno>
            <idno type="halUri">https://hal.science/hal-00849643</idno>
            <idno type="halBibtex">carreras:hal-00849643</idno>
            <idno type="halRefHtml">&lt;i&gt;Anticancer Research&lt;/i&gt;, 2010, 30 (7), pp.2977-84</idno>
            <idno type="halRef">Anticancer Research, 2010, 30 (7), pp.2977-84</idno>
            <availability status="restricted"/>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="UGA">HAL Grenoble Alpes</idno>
            <idno type="stamp" n="IMAG">IMAG</idno>
            <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
            <idno type="stamp" n="UNIV-GRENOBLE1">Université Joseph Fourier - Grenoble I</idno>
            <idno type="stamp" n="INPG">Institut polytechnique de Grenoble</idno>
            <idno type="stamp" n="APHP" corresp="INSERM">AP-HP</idno>
            <idno type="stamp" n="TIMC-IMAG">TIMC</idno>
            <idno type="stamp" n="TIMC-IMAG-THEREX" corresp="TIMC-IMAG">TheREx : Thérapeutique Recombinante Expérimentale</idno>
            <idno type="stamp" n="CHU-UNIV-PARIS5">Les centres hospitaliers de Paris Descartes</idno>
            <idno type="stamp" n="UNIV-LYON">Université de Lyon</idno>
            <idno type="stamp" n="TEST-UGA">TEST-UGA</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Influence on Busilvex pharmacokinetics of clonazepam compared to previous phenytoin historical data.</title>
                <author role="aut">
                  <persName>
                    <forename type="first">E.</forename>
                    <surname>Carreras</surname>
                  </persName>
                  <idno type="halauthorid">725981-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">J. Y.</forename>
                    <surname>Cahn</surname>
                  </persName>
                  <idno type="halauthorid">709469-0</idno>
                  <affiliation ref="#struct-388270"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">C.</forename>
                    <surname>Puozzo</surname>
                  </persName>
                  <idno type="halauthorid">505941-0</idno>
                  <affiliation ref="#struct-132311"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">N.</forename>
                    <surname>Kröger</surname>
                  </persName>
                  <idno type="idhal" notation="numeric">763386</idno>
                  <idno type="halauthorid" notation="string">725982-763386</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-2961-4183</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">G.</forename>
                    <surname>Sanz</surname>
                  </persName>
                  <idno type="halauthorid">725983-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">A.</forename>
                    <surname>Buzyn</surname>
                  </persName>
                  <idno type="halauthorid">423568-0</idno>
                  <affiliation ref="#struct-19365"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">A.</forename>
                    <surname>Bacigalupo</surname>
                  </persName>
                  <idno type="halauthorid">725984-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">J. P.</forename>
                    <surname>Vernant</surname>
                  </persName>
                  <idno type="halauthorid">440715-0</idno>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">22686</idno>
                <idno type="issn">0250-7005</idno>
                <title level="j">Anticancer Research</title>
                <imprint>
                  <publisher>International Institute of Anticancer Research</publisher>
                  <biblScope unit="volume">30</biblScope>
                  <biblScope unit="issue">7</biblScope>
                  <biblScope unit="pp">2977-84</biblScope>
                  <date type="datePub">2010-07</date>
                </imprint>
              </monogr>
              <idno type="pubmed">20683042</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <classCode scheme="mesh">Adolescent</classCode>
              <classCode scheme="mesh">Adult</classCode>
              <classCode scheme="mesh">Hematopoietic Stem Cell Transplantation</classCode>
              <classCode scheme="mesh">Humans</classCode>
              <classCode scheme="mesh">Immunosuppressive Agents</classCode>
              <classCode scheme="mesh">Male</classCode>
              <classCode scheme="mesh">Middle Aged</classCode>
              <classCode scheme="mesh">Phenytoin</classCode>
              <classCode scheme="mesh">Prospective Studies</classCode>
              <classCode scheme="mesh">Seizures</classCode>
              <classCode scheme="mesh">Transplantation Conditioning</classCode>
              <classCode scheme="mesh">Young Adult</classCode>
              <classCode scheme="mesh">Alkylating Agents</classCode>
              <classCode scheme="mesh">Anticonvulsants</classCode>
              <classCode scheme="mesh">Busulfan</classCode>
              <classCode scheme="mesh">Clonazepam</classCode>
              <classCode scheme="mesh">Cyclophosphamide</classCode>
              <classCode scheme="mesh">Drug Interactions</classCode>
              <classCode scheme="mesh">Female</classCode>
              <classCode scheme="mesh">Hematologic Neoplasms</classCode>
              <classCode scheme="halDomain" n="sdv.can">Life Sciences [q-bio]/Cancer</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>This study investigated the effect of seizure prophylaxis on busulfan (Bu) plasma exposure. Twenty-four adult patients received an intravenous Bu-cyclophoshamide conditioning regimen prior to bone marrow transplantation. Busilvex (0.8 mg/kg) was administered every six hours during four consecutive days. Clonazepam (0.025 to 0.03 mg/kg/day as a continuous 12-h i.v. infusion) was administered at least 12 hours prior to i.v. Bu dosing and continued until 24 hours after the last dose. Pharmacokinetic (PK) data were compared with those previously collected in patients (n=127) treated with phenytoin for seizure prophylaxis. Through population PK analysis, a 10% average increase (coefficient of variation, RSE=5.35%) in total clearance of Bu was quantified when Bu was associated with clonazepam as compared to phenytoin, which was considered as not being clinically relevant. The suspected induction on Bu metabolism by phenytoin should have resulted in the opposite effect. The patient efficacy and safety profiles were comparable between the two cohorts.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="researchteam" xml:id="struct-388270" status="INCOMING">
          <orgName>TheREx</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-707" type="direct"/>
            <relation active="#struct-51016" type="indirect"/>
            <relation active="#struct-89889" type="indirect"/>
            <relation active="#struct-301767" type="indirect"/>
            <relation name="UMR5525" active="#struct-441569" type="indirect"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-132311" status="INCOMING">
          <orgName>Institut de Recherche Pierre Fabre</orgName>
          <desc>
            <address>
              <addrLine>2 Rue Christian d'Espic;81106;Castres Cedex</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-302185" type="direct"/>
            <relation active="#struct-300556" type="indirect"/>
          </listRelation>
        </org>
        <org type="department" xml:id="struct-19365" status="VALID">
          <orgName>Service d'immuno-hématologie pédiatrique [CHU Necker]</orgName>
          <desc>
            <address>
              <addrLine>149 Rue de Sèvres, 75015 Paris</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-300068" type="direct"/>
            <relation active="#struct-414766" type="direct"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-707" status="OLD">
          <idno type="IdRef">14728936X</idno>
          <idno type="ISNI">0000 0004 4687 1979</idno>
          <idno type="RNSR">199511969L</idno>
          <idno type="ROR">https://ror.org/03985kf35</idno>
          <orgName>Techniques de l'Ingénierie Médicale et de la Complexité - Informatique, Mathématiques et Applications, Grenoble - UMR 5525</orgName>
          <orgName type="acronym">TIMC-IMAG</orgName>
          <date type="start">1993-01-01</date>
          <date type="end">2015-12-31</date>
          <desc>
            <address>
              <addrLine>Domaine de la Merci, 38706 La Tronche, France</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www-timc.imag.fr</ref>
          </desc>
          <listRelation>
            <relation active="#struct-51016" type="direct"/>
            <relation active="#struct-89889" type="direct"/>
            <relation active="#struct-301767" type="direct"/>
            <relation name="UMR5525" active="#struct-441569" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-51016" status="OLD">
          <idno type="IdRef">026404796</idno>
          <idno type="ROR">https://ror.org/02aj0kh94</idno>
          <orgName>Université Joseph Fourier - Grenoble 1</orgName>
          <orgName type="acronym">UJF</orgName>
          <date type="end">2015-12-31</date>
          <desc>
            <address>
              <addrLine>BP 53 - 38041 Grenoble Cedex 9</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.ujf-grenoble.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-89889" status="OLD">
          <idno type="IdRef">026388804</idno>
          <idno type="ROR">https://ror.org/05sbt2524</idno>
          <orgName>Institut polytechnique de Grenoble - Grenoble Institute of Technology</orgName>
          <orgName type="acronym">Grenoble INP</orgName>
          <date type="start">2007-01-01</date>
          <date type="end">2019-12-31</date>
          <desc>
            <address>
              <addrLine>46 avenue Félix Viallet 38031 Grenoble Cedex 1</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.grenoble-inp.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-301767" status="VALID">
          <idno type="ROR">https://ror.org/01c7wz417</idno>
          <orgName>VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement</orgName>
          <orgName type="acronym">VAS</orgName>
          <date type="start">2010-01-01</date>
          <desc>
            <address>
              <addrLine>Université de Lyon, VetAgro Sup, 69280 Marcy l'Etoile (campus vétérinaire); Université de Clermont, VetAgro Sup, 63370 Lempdes (campus agronomique)</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.vetagro-sup.fr/</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-441569" status="VALID">
          <idno type="IdRef">02636817X</idno>
          <idno type="ISNI">0000000122597504</idno>
          <idno type="ROR">https://ror.org/02feahw73</idno>
          <orgName>Centre National de la Recherche Scientifique</orgName>
          <orgName type="acronym">CNRS</orgName>
          <date type="start">1939-10-19</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.cnrs.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-302185" status="VALID">
          <orgName>Centre de Recherche Pierre Fabre</orgName>
          <orgName type="acronym">Centre de R&amp;D Pierre Fabre</orgName>
          <desc>
            <address>
              <addrLine>Oncopole, 3 Av. Hubert Curien, 31100 Toulouse</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.oncopole-toulouse.com/fr/la-recherche-privee</ref>
          </desc>
          <listRelation>
            <relation active="#struct-300556" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-300556" status="VALID">
          <orgName>PIERRE FABRE</orgName>
          <date type="start">1962-01-01</date>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.pierre-fabre.com</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-300068" status="VALID">
          <idno type="ROR">https://ror.org/00pg5jh14</idno>
          <orgName>Assistance publique - Hôpitaux de Paris (AP-HP)</orgName>
          <orgName type="acronym">AP-HP</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="institution" xml:id="struct-414766" status="VALID">
          <orgName>Hôpital Necker - Enfants Malades [AP-HP]</orgName>
          <desc>
            <address>
              <addrLine>149 Rue de Sèvres 75015 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://hopital-necker.aphp.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-300068" type="direct"/>
          </listRelation>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>